# US 2003/0233679 A1 · Methods for controlling gibberellin levels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0233679 A1
- Document ID: US20030233679A1
- Status: Published application
- Kind: A1
- Application number: 10/401,321
- Filed: 2003-03-27
- Published: 2003-12-18
- Earliest claimed: 1998-08-10
- Assignees: Monsanto Technology LLC
- Inventors: Sherri M. Brown; Tedd D. Elich; Gregory R. Heck; Ganesh M. Kishore; Eugene W. Logusch; Sherry J. Logusch; Kenneth J. Piller; Sudabathula Rao; Joel E. Ream; Scott R. Baerson
- Web page: https://patentgrep.com/patent/US20030233679A1

## CPC

- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/00: Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00)
- C12N 9/0069: {acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)}
- C12N 15/8222: {Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation}
- C12N 15/8243: {involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine}
- C12N 15/8297: {Gibberellins; GA3}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-β hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3β-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2β,3β-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.

## Claims

### Claim 1

A method of growing a transgenic plant comprising:
providing a transgenic plant or a seed or seedling thereof comprising a transgene, the transgene comprising a promoter and, operably linked to the promoter, a sequence that, when expressed, alters the level of a hormone and causes at least one phenotype in the transgenic plant or seed or seedling thereof that is abnormal compared with an otherwise identical plant or seed or seedling thereof that lacks the transgene;
applying a composition that comprises a first compound that is metabolized by the seed or seedling to produce a second compound that substantially eliminates the abnormal phenotype to the transgenic plant or seed or seedling thereof; and
growing the transgenic plant or seed or seedling thereof to produce a phenotypically normal transgenic plant.

### Claim 2 (depends on 1)

The method of claim 1, wherein:
the hormone is a gibberellin; and
the first compound is a GA compound.

### Claim 3 (depends on 2)

The method of claim 2, wherein the sequence, when expressed, causes at least one phenotype selected from the group consisting of a shortened hypocotyl, shortened epicotyl, and both a shortened hypocotyl and shortened epicotyl.

### Claim 4 (depends on 2)

The method claim 2, wherein the first compound is a gibberellin precursor or a gibberellin biosynthetic intermediate.

### Claim 5 (depends on 2)

The method of claim 2, wherein the first compound is ent-kaurene, ent-kaurenoic acid, ent-7α-hydroxykaurenoic acid, steviol, GA12-aldehyde, GA12, GA15, GA24, GA9, GA53, GA44, GA19, GA20, GA5, or GA3-3-acetate.

### Claim 6 (depends on 2)

The method of claim 2, wherein the first compound is GA9, GA15, GA19, GA24, GA44, GA53, GA5, or steviol.

### Claim 7 (depends on 1)

The method of claim 1, wherein the sequence, when expressed, reduces expression of an enzyme in the pathway for biosynthesis of the hormone.

### Claim 8 (depends on 7)

The method of claim 7, wherein the sequence is in an antisense orientation with respect to the promoter.

### Claim 9 (depends on 7)

The method of claim 7, wherein the enzyme is copalyl diphosphate synthase, a 3β-hydroxylase, or a C-20 oxidase.

### Claim 10 (depends on 9)

The method of claim 9, wherein the sequence comprises at least 15 contiguous nucleotides of, or that hybridizes under high stringency conditions to, SEQ ID NO: 1, 2, 3, 4, 5, 6, 8, or complements thereof.

### Claim 11 (depends on 1)

The method of claim 1, wherein the sequence encodes an enzyme that inactivates the hormone.

### Claim 12 (depends on 11)

The method of claim 11, wherein:
the hormone is a gibberellin; and
the sequence encodes a GA 2-oxidase.

### Claim 13 (depends on 12)

The method of claim 12, wherein the sequence has at least 85% nucleotide sequence identity with SEQ ID NO: 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, or 71.

### Claim 14 (depends on 12)

The method of claim 12, wherein the sequence encodes a GA 2-oxidase having at least 70% amino acid sequence identity with an Arabidopsis GA 2-oxidase 4, an Arabidopsis 2-oxidase 5, a soybean GA 2-oxidase 1, a soybean GA 2-oxidase 2, a cotton GA 2 oxidase-1, a cotton GA 2 oxidase-2, a cotton GA 2 oxidase-3, a maize GA 2-oxidase 1, or a maize 2-oxidase 2.

### Claim 15 (depends on 1)

The method of claim 1, wherein the sequence encodes an enzyme that metabolizes a precursor of the hormone to produce a metabolite that is not a precursor of the hormone in the transgenic plant.

### Claim 16 (depends on 15)

The method of claim 15, wherein:
the hormone is a gibberellin; and
the enzyme is a phytoene synthase, a C-20 oxidase, or a 2β,3β-hydroxylase.

### Claim 17 (depends on 16)

The method of claim 16, wherein the sequence has at least 85% nucleotide sequence identity with SEQ ID NO: 75, 77, or 79.

### Claim 18 (depends on 16)

The method of claim 16, wherein the sequence encodes an enzyme having at least 70% amino acid sequence identity with a tomato phytoene synthase, a pumpkin C-20 oxidase, or a pumpkin 2β,3β-hydroxylase.

### Claim 19 (depends on 1)

The method of claim 1, wherein the promoter is preferentially expressed in developing seeds, during seed germination, or in young seedlings.

### Claim 20 (depends on 1)

The method of claim 1, comprising applying the composition to soil or directly to the seed or seedling.

### Claim 21

A method of growing a transgenic plant comprising:
providing a transgenic plant or a seed or seedling thereof comprising a transgene, the transgene comprising a promoter and, operably linked to the promoter, a sequence that, when expressed, alters the level of an enzyme in the gibberellin biosynthetic pathway and causes a phenotype in the transgenic plant or the seed or seedling thereof that is abnormal compared with an otherwise identical plant or seed or seedling thereof that lacks the transgene;
applying a composition that comprises at least one GA compound to the transgenic plant or the seed or seedling thereof, and
growing the transgenic plant or the seed or seedling thereof to produce a phenotypically normal transgenic plant.

### Claim 22 (depends on 21)

The method of claim 21, wherein the enzyme is a copalyl diphosphate synthase, a 3β-hydroxylase, or a C-20 oxidase.

### Claim 23 (depends on 22)

The method of claim 22, wherein the sequence comprises a member of the group consisting of:
a) at least 15 contiguous nucleotides of SEQ ID NO: 1, 2, 3, 4, 5, 6, or 8;
b) a sequence having at least 85% nucleotide sequence identity with SEQ ID NO: 1, 2,3,4,5,6, or 8; and
c) a sequence that encodes a polypeptide having at least 70% amino acid sequence identity with a polypeptide encoded by member of the group consisting of SEQ ID NO: I, 2, 3, 4, 5, 6, 8.

### Claim 24 (depends on 21)

The method of claim 21, wherein the promoter is preferentially expressed in developing seeds, during seed germination, or in early seedlings.

### Claim 25 (depends on 21)

The method of claim 21, wherein the GA compound is ent-kaurene, ent-kaurenoic acid, ent-7α-hydroxykaurenoic acid, steviol, GA12-aldehyde, GA15, GA19, GA24, GA9, GA53, GA44, GA19, GA20, GA5, GA4. GA7, GA3. or GA3-3-acetate.

### Claim 26 (depends on 21)

The method of claim 21, wherein the GA compound is GA9, GA15, GA19, GA24, GA44, GA53, GA5, or steviol.

### Claim 27 (depends on 21)

The method of claim 21, wherein the promoter is preferentially expressed in developing seeds, during seed germination, or in early seedlings.

### Claim 28

A method of growing a transgenic plant comprising:
providing a transgenic plant or a seed or seedling thereof comprising a transgene, the transgene comprising a promoter and, operably linked to the promoter, a sequence that encodes an enzyme that inactivates an endogenous gibberellin, causing at least one phenotype in the transgenic plant or the seed or seedling thereof that is abnormal compared with an otherwise identical plant or seed or seedling thereof that lacks the transgene;
applying a composition that comprises at least one GA compound that is metabolized by the seed or seedling to produce a product having gibberellin activity that is not inactivated by the enzyme to the transgenic plant or the seed or seedling thereof; and
growing the transgenic plant or the seed or seedling thereof to produce a phenotypically normal transgenic plant.

### Claim 29 (depends on 28)

The method of claim 28, wherein the enzyme is a GA 2-oxidase.

### Claim 30 (depends on 29)

The method of claim 29, wherein the sequence has at least 85% nucleotide sequence identity with SEQ ID NO: 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, or 71.

### Claim 31 (depends on 30)

The method of claim 30, wherein the sequence encodes a GA 2-oxidase having at least 70% amino acid identity with an Arabidopsis GA 2-oxidase 4, an Arabidopsis 2-oxidase 5, a soybean GA 2-oxidase 1, a soybean GA 2-oxidase 2, a cotton GA 2 oxidase-1, a cotton GA 2 oxidase-2, a cotton GA 2 oxidase-3, a maize GA 2-oxidase 1, or a maize 2-oxidase 2.

### Claim 32 (depends on 28)

The method of claim 28, wherein the promoter is preferentially expressed in developing seeds, during seed germination, or in early seedlings.

### Claim 33 (depends on 28)

The method of claim 28, wherein the GA compound is GA4, GA7, GA3, or GA3-3-acetate.

### Claim 34 (depends on 33)

The method of claim 33, wherein the GA compound is GA3 or GA3-3-acetate.

### Claim 35

A method of growing a transgenic plant comprising:
providing a transgenic plant or a seed or seedling thereof comprising a transgene, the transgene comprising a promoter and, operably linked to the promoter, a sequence that encodes an enzyme that metabolizes a gibberellin precursor to produce a metabolite that is not a gibberellin precursor, thereby reducing the level of a gibberellin and causing at least one phenotype in the transgenic plant or the seed or seedling thereof that is abnormal compared with an otherwise identical plant or seed or seedling thereof that lacks the transgene;
applying a composition that comprises at least one GA compound that substantially eliminates the abnormal phenotype to the seed or seedling of the transgenic plant; and
growing the transgenic plant or seed or seedling thereof to produce a phenotypically normal transgenic plant.

### Claim 36 (depends on 35)

The method of claim 35, wherein the enzyme is a phytoene synthase, a C-20 oxidase, or a 2β,3β-hydroxylase.

### Claim 37 (depends on 35)

The method of claim 35, wherein the enzyme is a tomato phytoene synthase, a pumpkin C-20 oxidase, or a pumpkin 2β,3β-hydroxylase.

### Claim 38 (depends on 36)

The method claim 36, wherein:
the enzyme is a phytoene synthase; and
the GA compound is ent-kaurene, ent-kaurenoic acid, ent-7α-hydroxykaurenoic acid, steviol, GA12-aldehyde, GA12, GA15, GA24, GA9, GA53, GA44, GA19, GA20, GA5, GA4, GA7, GA3, or GA3-3-acetate.

### Claim 39 (depends on 36)

The method of claim 36, wherein:
the enzyme is a phytoene synthase; and
the GA compound is GA9, GA,5, GA19, GA24, GA44, GA53, GA5 or steviol.

### Claim 40 (depends on 36)

The method claim 36, wherein:
the enzyme is a C-20 oxidase; and
the GA compound is GA9, GA4, GA20, GA1, GA7, GA3, or GA3-3-acetate.

### Claim 41 (depends on 36)

The method of claim 36, wherein:
the enzyme is a C-20 oxidase; and
the GA compound is GA3 or GA3-3-acetate.

### Claim 42 (depends on 36)

The method claim 36, wherein:
the enzyme is a 2β,3β-hydroxylase; and
the GA compound is GA9, GA41, GA53, GA44, GA19, GA20, GA15, GA7, GA3 or GA3-3-acetate.

### Claim 43 (depends on 40)

The method of claim 40, wherein the GA compound is GA3 or GA3-3-acetate.

### Claim 44 (depends on 35)

The method of claim 35, wherein the promoter is preferentially expressed in developing seeds, during seed germination, or in early seedlings.

### Claim 45

A nucleic acid segment comprising at least 12 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 1, 2, 3, 4, 5, 6, 8, 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, 75, 77, 79, and complements thereof, wherein the nucleic acid segment hybridizes specifically to the selected sequence under stringent hybridization conditions.

### Claim 46

A nucleic acid construct comprising operably linked:
a promoter that causes expression of an operably linked nucleic acid segment in a plant cell; and
a nucleic acid segment comprising at least 12 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 1, 2, 3, 4, 5, 6, 8, 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, 75, 77, 79, and complements thereof, wherein the nucleic acid segment hybridizes specifically to the selected sequence under stringent hybridization conditions.

### Claim 47 (depends on 45)

The nucleic acid construct of claim 45, wherein:
the nucleic acid segment is SEQ ID NO: 1, 2, 3, 4, 5, 6, or 8; and
expression of the nucleic acid segment in the plant cell reduces a level of an endogenous gibberellin compared with an otherwise identical plant cell in which the nucleic acid segment is not expressed.

### Claim 48 (depends on 47)

The nucleic acid segment of claim 47, wherein the nucleic acid segment is in antisense orientation with respect to the promoter.

### Claim 49

A transgenic plant comprising a nucleic acid segment comprising at least 12 contiguous nucleotides of a sequence selected from the group consisting of SEQ ID NO: 1, 2, 3,4, 5, 6, 8, 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, 75, 77, 79, and complements thereof, wherein the nucleic acid segment hybridizes specifically to the selected sequence under stringent hybridization conditions.

### Claim 50 (depends on 49)

The transgenic plant of claim 49, characterized by at least one phenotype selected from the group consisting of a shortened hypocotyl, shortened epicotyl, and both a shortened hypocotyl and shortened epicotyl compared with an otherwise identical plant that lacks the nucleic acid segment.

### Claim 51

A nucleic acid segment comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 1, 2, 3, 4, 5, 6, 8, 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, 75, 77, 79, or complements thereof.

### Claim 52 (depends on 51)

The nucleic acid segment of claim 51, comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 1, 2, 3, 4, or complements thereof, wherein the sequence encodes a polypeptide with copalyl diphosphate synthase activity.

### Claim 53 (depends on 51)

The nucleic acid segment of claim 51, comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 5, 6, or complements thereof, wherein the sequence encodes a polypeptide with 3β-hydroxylase activity.

### Claim 54 (depends on 51)

The nucleic acid segment of claim 51, comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 8, 77, or complements thereof, wherein the sequence encodes a polypeptide with C-20 oxidase activity.

### Claim 55 (depends on 51)

The nucleic acid segment of claim 51, comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, or complements thereof, wherein the sequence encodes a polypeptide with GA 2-oxidase activity.

### Claim 56 (depends on 51)

The nucleic acid segment of claim 51, comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 75 or the complement thereof, wherein the sequence encodes a polypeptide with phytoene synthase activity.

### Claim 57 (depends on 51)

The nucleic acid segment of claim 51, comprising a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO: 79 or the complement thereof, wherein the sequence encodes a polypeptide with 2β,3β-hydroxylase activity.

### Claim 58

A transgenic plant comprising a nucleic acid segment; wherein the nucleic acid segment comprises a sequence of at least 100 nucleotides having at least 85% nucleotide sequence identity with SEQ ID NO:l, 2, 3, 4, 5, 6, 8, 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, 75, 77, 79, or complements thereof.

### Claim 59 (depends on 58)

The transgenic plant of claim 58, characterized by at least one phenotype selected from the group consisting of a shortened hypocotyl, shortened epicotyl, and both a shortened hypocotyl and shortened epicotyl compared with an otherwise identical plant that lacks the nucleic acid segment.

### Claim 60

A nucleic acid construct comprising a promoter that causes expression of an operably linked nucleic acid segment in a plant cell and, operably linked to the promoter, the nucleic acid segment comprising a sequence that encodes a polypeptide having a GA 2-oxidase activity, wherein expression of the nucleic acid segment in the plant cell results in inactivation of an endogenous gibberellin in the plant cell, thereby reducing levels of the endogenous gibberellin in the plant cell compared with an otherwise identical plant cell in which the nucleic acid segment is not expressed.

### Claim 61 (depends on 60)

The nucleic acid construct of claim 60, wherein the sequence encodes a polypeptide having at least 70% amino acid sequence identity with a polypeptide encoded by SEQ ID NO: 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, or the complements thereof.

### Claim 62 (depends on 61)

The nucleic acid segment of claim 61, encoding a polypeptide having only silent or conservative substitutions to the polypeptide encoded by SEQ ID NO: 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, or the complements thereof.

### Claim 63 (depends on 61)

The nucleic acid segment of claim 61, encoding a polypeptide identical to the polypeptide encoded by SEQ ID NO: 57, 58, 60, 62, 64, 66, 67, 68, 69, 70, 71, or the complements thereof.

### Claim 64

A transgenic plant comprising a nucleic acid segment, wherein the nucleic acid segment comprises a promoter that causes expression of an operably linked nucleic acid segment in a plant cell and, operably linked to the promoter, the nucleic acid segment comprising a sequence that encodes a polypeptide having a GA 2-oxidase activity, wherein expression of the nucleic acid segment in the plant cell results in inactivation of an endogenous gibberellin in the plant cell, thereby reducing levels of the endogenous gibberellin in the plant cell compared with an otherwise identical plant cell in which the nucleic acid segment is not expressed.

### Claim 65 (depends on 64)

The transgenic plant of claim 64, characterized by at least one phenotype selected from the group consisting of a shortened hypocotyl, shortened epicotyl, and both a shortened hypocotyl and shortened epicotyl compared with an otherwise identical plant that lacks the nucleic acid segment.

### Claim 66

A nucleic acid construct comprising a promoter that causes expression of an operably linked nucleic acid segment in a plant cell and, operably linked to the promoter, a nucleic acid segment encoding a polypeptide having an activity selected from the group consisting of phytoene synthase activity, a C-20 oxidase activity, and a 2β,3β-hydroxylase activity, wherein expression of the nucleic acid segment in the plant cell results in metabolism of a gibberellin precursor in the plant cell to produce a metabolite that is not a gibberellin precursor in the plant cell, thereby reducing levels of the endogenous gibberellin in the plant cell compared with an otherwise identical plant cell in which the nucleic acid segment is not expressed.

### Claim 67 (depends on 66)

The nucleic acid construct of claim 66, wherein the sequence encodes a polypeptide having at least 70% amino acid sequence identity with a polypeptide encoded by SEQ ID NO: 75, 77, 79, or the complements thereof.

### Claim 68 (depends on 66)

The nucleic acid segment of claim 66, encoding a polypeptide having only silent or conservative substitutions to the polypeptide encoded by SEQ ID NO: 75, 77, 79, or the complements thereof.

### Claim 69 (depends on 66)

The nucleic acid segment of claim 66, encoding a polypeptide identical to the polypeptide encoded by SEQ ID NO: 75, 77, 79, or the complements thereof.

### Claim 70

A transgenic plant comprising a nucleic acid segment, wherein the nucleic acid segment comprises a promoter that causes expression of an operably linked nucleic acid segment in a plant cell and, operably linked to the promoter, a nucleic acid segment encoding a polypeptide having an activity selected from the group consisting of phytoene synthase activity, a C-20 oxidase activity, and a 2β,3β-hydroxylase activity, wherein expression of the nucleic acid segment in the plant cell results in metabolism of a gibberellin precursor in the plant cell to produce a metabolite that is not a gibberellin precursor in the plant cell, thereby reducing levels of the endogenous gibberellin in the plant cell compared with an otherwise identical plant cell in which the nucleic acid segment is not expressed.

### Claim 71 (depends on 70)

The transgenic plant of claim 70, characterized by at least one phenotype selected from the group consisting of a shortened hypocotyl, shortened epicotyl, and both a shortened hypocotyl and shortened epicotyl compared with an otherwise identical plant that lacks the nucleic acid segment.

### Claim 72

A promoter that is operable in a plant cell, the promoter comprising at least 15 contiguous nucleotides of SEQ ID NO: 7.

### Claim 73 (depends on 72)

The promoter of claim 72, comprising at least 100 contiguous nucleotides of SEQ ID NO: 7.

### Claim 74 (depends on 73)

The promoter of claim 73, that is preferentially expressed in seedlings.

### Claim 75

A transgenic plant comprising a promoter, wherein the promoter comprises at least 15 contiguous nucleotides of SEQ ID NO: 7.

### Claim 76

A composition comprising:
one or more seeds of a plant that has a gibberellin-deficiency that results in at least one abnormal phenotype in the seed or in a seedling of the plant compared with a seed or seedling of an otherwise identical plant having wild-type levels of gibberellin; and
a composition applied to a surface of the seed that comprises an amount of at least one GA compound that is effective to substantially eliminate the abnormal phenotype.

### Claim 77 (depends on 76)

The composition of claim 76, wherein the GA compound is ent-kaurene, ent-kaurenoic acid, ent-7α-hydroxykaurenoic acid, steviol, GA12-aldehyde, GA12, GA15, GA24, GA9, GA53, GA44, GA19, GA20, or GA5.

### Claim 78 (depends on 76)

The composition of claim 76, wherein the GA compound is GA9, GA15, GA19, GA24, GA44, GA53, GA5, or steviol.

### Claim 79 (depends on 76)

The composition of claim 76, wherein the plant is a transgenic plant comprising a transgene comprising a promoter and, operably linked to the promoter, a sequence that, when expressed, reduces gibberellin levels in the seed or seedling.
